Prostatic paracoccidioidomycosis: differential diagnosis of prostate cancer.
Symptomatic prostatic paracoccidioidomycosis (PCM) is a very rare condition; however, it may express as a typical benign prostatic hyperplasia or a simulating prostatic adenocarcinoma. This case report presents PCM mimicking prostatic adenocarcinoma. The purpose of this paper is to call the general physician's attention to this important differential diagnosis.
Lopes
Daniel Lima
DL
Hospital do Instituto de Previdência dos Servidores do Estado de Minas Gerais, Belo Horizonte, MG, Brasil.
Araújo
Stanley de Almeida
Sde A
Santos
João Paulo Lemos da Silveira
JP
Lyon
Ana Claudia
AC
Dantas
Diogo Vieira
DV
Reis
Bernardo Sgarbi
BS
de Góes
Alfredo Miranda
AM
Pedroso
Enio Roberto Pietra
ER
D000981:Antiprotozoal Agents / Q000627:therapeutic use; D003937:Diagnosis, Differential; D006801:Humans; D017964:Itraconazole / Q000627:therapeutic use; D008297:Male; D008875:Middle Aged; D010228:Paracoccidioides / Q000302:isolation & purification; D010229:Paracoccidioidomycosis / Q000175:diagnosis* / Q000188:drug therapy; D017430:Prostate-Specific Antigen / Q000097:blood; D011470:Prostatic Hyperplasia / Q000188:drug therapy / Q000469:parasitology*; D011471:Prostatic Neoplasms / Q000175:diagnosis*; D013420:Sulfamethoxazole / Q000627:therapeutic use; D014295:Trimethoprim / Q000627:therapeutic use
D000981:Antiprotozoal Agents; D017964:Itraconazole; D014295:Trimethoprim; D017430:Prostate-Specific Antigen; D013420:Sulfamethoxazole